General European Strategic Investments announces passing of CEO Wolfgang Rauball
[ad_1]
General European Strategic Investments announces passing of CEO Wolfgang Rauball
[ad_2]
[ad_1] SA Asks: Which biotechs are most likely to be acquired near-term? [ad_2]
[ad_1] Grandbrothers Johnson & Johnson (NYSE:JNJ) has received Priority Review designation from the FDA for the Biologics License Application for its drug nipocalimab in the treatment of antibody-positive patients with generalized myasthenia gravis. Nipocalimab was also recently granted Breakthrough Therapy Designation by [ad_2]
[ad_1] Viking Therapeutics among potential buyout candidates: Oppenheimer [ad_2]
[ad_1] Bitcoin falls to lowest level since November as investors reassessed rate cut bets [ad_2]
[ad_1] ASML in focus as Dutch government says it will expand export control curbs [ad_2]
[ad_1] JHVEPhoto AllianceBernstein’s (NYSE:AB) preliminary assets under management dropped to $792B at Dec. 31, 2024, from $813B at Nov. 30, due to market declines and net outflows across all three of its channels, the company said on Monday. During the month, the S&P 500 fell by 2.3%. [ad_2]